C3 glomerulopathy: a new classification, Nat Rev Nephrol, vol.6, pp.494-499, 2010. ,
Toward a working definition of C3 glomerulopathy by immunofluorescence, Kidney Int, vol.85, pp.450-456, 2014. ,
, C3 glomerulopathy: consensus report, vol.84, pp.1079-1089, 2013.
Membranoproliferative glomerulonephritisa new look at an old entity, N Engl J Med, vol.366, pp.1119-1131, 2012. ,
Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement, Clin J Am Soc Nephrol, vol.6, pp.1009-1017, 2011. ,
Complement System Part I -Molecular Mechanisms of Activation and Regulation, Front Immunol, vol.6, 2015. ,
, Complement System Part II: Role in Immunity. Front Immunol, vol.6, 2015.
Membranoproliferative glomerulonephritis type II (dense deposit disease): an update, J Am Soc Nephrol, vol.16, pp.1392-1403, 2005. ,
Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies, Kidney Int, vol.82, pp.454-464, 2012. ,
Autoantibodies against complement components and functional consequences, Mol Immunol, vol.56, pp.213-221, 2013. ,
, Factor H autoantibodies in membranoproliferative glomerulonephritis, vol.52, pp.200-206, 2012.
Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis, Lancet, vol.376, pp.794-801, 2010. ,
Rodríguez de Córdoba S: Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation, J Clin Invest, vol.120, pp.3702-3712, 2010. ,
Alternative complement pathway assessment in patients with atypical HUS, J Immunol Methods, vol.365, pp.8-26, 2011. ,
Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGF, Kidney Int, vol.69, pp.1633-1640, 2006. ,
, Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome, vol.114, pp.2837-2845, 2009.
Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome, Blood, vol.122, pp.282-292, 2013. ,
Complement factor B mutations in atypical hemolytic uremic syndrome-disease-relevant or benign?, J Am Soc Nephrol, vol.25, pp.2053-2065, 2014. ,
Fremeaux-Bacchi V: A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function, Blood, vol.119, pp.4182-4191, 2012. ,
Structures of C3b in complex with factors B and D give insight into complement convertase formation, Science, vol.330, pp.1816-1820, 2010. ,
3D structure of the C3bB complex provides insights into the activation and regulation of the complement alternative pathway convertase, Proc Natl Acad Sci U S A, vol.106, pp.882-887, 2009. ,
Coexistence of closed and open conformations of complement factor B in the alternative pathway C3bB(Mg2+) proconvertase, J Immunol, vol.183, pp.7347-7351, 2009. ,
Structure of complement fragment C3b-factor H and implications for host protection by complement regulators, Nat Immunol, vol.10, pp.728-733, 2009. ,
Structure of the extracellular portion of CD46 provides insights into its interactions with complement proteins and pathogens, PLoS Pathog, vol.6, p.1001122, 2010. ,
Identification of the C3b receptor-binding domain in third component of complement, J Biol Chem, vol.263, pp.14586-14591, 1988. ,
Structural insights into the central complement component C3, Mol Immunol, vol.44, pp.3-10, 2007. ,
Identification of residues within the 727-767 segment of human complement component C3 important for its interaction with factor H and with complement receptor 1 (CR1, CD35) ,
, J Biol Chem, vol.274, pp.5120-5130, 1999.
Competition for binding sites on C3b by CR1, CR2, MCP, factor B and factor H, Complement Inflamm, vol.7, pp.30-41, 1990. ,
Dissection of CR1, factor H, membrane cofactor protein, and factor B binding and functional sites in the third complement component, J Immunol, vol.156, pp.4821-4832, 1996. ,
Loss of DGK« induces endothelial cell activation and death independently of complement activation, Blood, vol.125, pp.1038-1046, 2015. ,
Structural basis for complement factor I control and its disease-associated sequence polymorphisms, Proc Natl Acad Sci U S A, vol.108, pp.12839-12844, 2011. ,
Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults, Clin J Am Soc Nephrol, vol.8, pp.554-562, 2013. ,
Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome, Blood, vol.112, pp.4948-4952, 2008. ,
Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype, Clin J Am Soc Nephrol, vol.5, pp.1844-1859, 2010. ,
Fremeaux-Bacchi V: Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome, Blood, vol.125, pp.2359-2369, 2015. ,
Immunohistochemical study of the human glomerular C3b receptor in normal kidney and in seventy-five cases of renal diseases: loss of C3b receptor antigen in focal hyalinosis and in proliferative nephritis of systemic lupus erythematosus, J Clin Invest, vol.69, pp.900-912, 1982. ,
CRIT is expressed on podocytes in normal human kidney and upregulated in membranous nephropathy, Kidney Int, vol.69, 1961. ,
No complement receptor 1 stumps on podocytes in human glomerulopathies, Kidney Int, vol.59, pp.160-168, 2001. ,
Localization of the complement regulatory proteins in the normal human kidney, Kidney Int, vol.46, pp.89-96, 1994. ,
C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up, Kidney Int, vol.82, pp.465-473, 2012. ,
Glomeruli of Dense Deposit Disease contain components of the alternative and terminal complement pathway, Kidney Int, vol.75, pp.952-960, 2009. ,
Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice, J Clin Invest, vol.118, pp.608-618, 2008. ,
,
, French Study Group for aHUS/C3G: Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies, Nat Rev Nephrol, vol.8, pp.643-657, 2012.
Soluble CR1 therapy improves complement regulation in C3 glomerulopathy, J Am Soc Nephrol, vol.24, pp.1820-1829, 2013. ,
Hypocomplementaemia of poststreptococcal acute glomerulonephritis is associated with C3 nephritic factor (C3NeF) IgG autoantibody activity, Nephrol Dial Transplant, vol.9, pp.1747-1750, 1994. ,
Overall neutralization of complement factor H by autoantibodies in the acute phase of the autoimmune form of atypical hemolytic uremic syndrome, J Immunol, vol.189, pp.3528-3537, 2012. ,
Combined C3b and factor B autoantibodies and MPGN type II, N Engl J Med, vol.365, pp.2340-2342, 2011. ,
Structure of C3b reveals conformational changes that underlie complement activity, Nature, vol.444, pp.213-216, 2006. ,
Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor, Nat Immunol, vol.10, pp.721-727, 2009. ,
Functional evaluation of factor H genetic and acquired abnormalities: application for atypical hemolytic uremic syndrome (aHUS), Methods Mol Biol, vol.1100, pp.237-247, 2014. ,
Functional analysis in serum from atypical Hemolytic Uremic Syndrome patients reveals impaired protection of host cells associated with mutations in factor H, Mol Immunol, vol.41, pp.81-84, 2004. ,
The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome, J Immunol, vol.182, pp.7009-7018, 2009. ,
Mundel P: A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression, J Am Soc Nephrol, vol.13, pp.630-638, 2002. ,
Nucleophilic modification of human complement protein C3: correlation of conformational changes with acquisition of C3b-like functional properties, Biochemistry, vol.20, pp.4458-4467, 1981. ,
Self-association and domain rearrangements between complement C3 and C3u provide insight into the activation mechanism of C3, Biochem J, vol.431, pp.63-72, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00517253
Structural transitions of complement component C3 and its activation products, Proc Natl Acad Sci U S A, vol.103, 2006. ,
Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3, J Exp Med, vol.154, pp.856-867, 1981. ,
A revised mechanism for the activation of complement C3 to C3b: a molecular explanation of a disease-associated polymorphism, J Biol Chem, vol.290, pp.2334-2350, 2015. ,
Solvent accessibility of native and hydrolyzed human complement protein 3 analyzed by hydrogen/ deuterium exchange and mass spectrometry, J Immunol, vol.174, pp.3469-3474, 2005. ,